MenQuadfi
meningococcal group A, C, W-135 and Y conjugate vaccine
Meningitis, Meningococcal
Date of authorisation:
Revision: 12
Last updated:
MedicineHumanAuthorised
EMEA-001468-PIP01-13 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Neurology
PIP number: P/0081/2014
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule
Coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Nimenrix
meningococcal groups A, C, W-135 and Y conjugate vaccine
Meningitis, Meningococcal
Date of authorisation:
Revision: 36
Last updated:
MedicineHumanAuthorised
EMEA-001930-PIP01-16-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0222/2022
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000429-PIP01-08-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0089/2015
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Powder and solvent for solution for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Globorix
Diphtheria toxoid
Tetanus toxoid
Bordetella pertussis (inactivated)
Haemophilus influenzae type b polysaccharide
Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid
Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid
hepatitis B surface antigen
Immunization
Hepatitis B
Diphtheria-Tetanus-Pertussis Vaccine
Bordetella pertussis
Haemophilus influenzae type b
Neisseria meningitidis, Serogroup A
Neisseria meningitidis, Serogroup C
Withdrawn application
Last updated:
EU-M4allHuman